CSC Securities has noted that China's AI-powered medical industry is poised for continued advancements in 2025, spanning policies, technologies, products, and applications. From a technological standpoint, the industry will shift from achieving breakthroughs in individual products to constructing comprehensive, scenario-based chains. In terms of application, the reach will extend from large hospitals to primary healthcare facilities and individual users. AI-driven medical applications offer immense potential in enhancing the functionality of medical devices, interpreting test results, aiding doctors in decision-making processes, and facilitating health management. These applications represent an innovative direction that medical enterprises and hospitals should prioritize.

With the driving force of supportive policies and technological advancements, the implementation of AI-powered medical industry application scenarios is expected to gather momentum. It is also anticipated that other regions will follow suit and introduce relevant policies. Therefore, investors are advised to stay attuned to the investment opportunities within this burgeoning industry.